Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro, JJ. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro, JJ
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial fibrillation as a contributory cause of death, 2011
    Atrial fibrillation is a contributory cause of death for around 93,000 Americans each year.  
  • Average age of AFib patients
    The mean age for atrial fibrillation is 66.8 years in men and 74.6 years in women.  
  • AFib prevalence rate projection, 2050
    By 2050, it is estimated that 88% of Americans with atrial fibrillation will be age 65 and older.  
  • Atrial fibrillation prevalence, 2001
    An estimated 2.66 million Americans currently have atrial fibrillation.  
  • AFib prevalence as population ages
    As our population continues to age, prevalence of Afib is going to skyrocket, to a projected 5.6 to 15.9 million adults by 2050.